TerminatedPhase 4ACTRN12610000873022

effectiveness of local dental anaesthetic in children

effectiveness of Articaine 4% with 1:100,000 adrenaline in obtaining local dental analgesia of the lower back teeth among children


Sponsor

Dental Health Services, Western Australia

Enrollment

150 participants

Start Date

Mar 10, 2010

Study Type

Interventional

Conditions

Summary

The aim of the study is to determine if Articaine was more effective than Lignocaine in achieving local analgesia for dental fillings in the back teeth in the lower jaw among children when using two different techniques of anaesthetic delivery. The null hypothesis is that there is no difference in achieving local analgesia between Articaine 4% and Lignocaine 2%.


Eligibility

Sex: Both males and femalesMin Age: 5 YearssMax Age: 17 Yearss

Plain Language Summary

Simplified for easier understanding

This study compares different types of dental numbing injections in children to find out which works best for filling cavities. It is open to children aged 5 to 17 who need fillings on both sides of their lower jaw and weigh at least 20 kg.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Comparison of the effectiveness of articaine 4% against lignocaine 2% in obtaining dental local analgesia among children when delivered as a buccal infiltration or inferior alveolar nerve block injec

Comparison of the effectiveness of articaine 4% against lignocaine 2% in obtaining dental local analgesia among children when delivered as a buccal infiltration or inferior alveolar nerve block injections for restorative procedures in mandibular posterior teeth. Dosage of trial anaesthetic limited only to a maximum of 2.2 ml cartridge of the local anaesthetic agent. Dosage of local analgesic agent titrated to maximum of 5 mg/kg body weight. If local analgesia was not achieved with the trial anaesthetic patient reappointed for another appointment for the treatment to be completed using standard treatment protocol or supplement with standard local anaesthetic (Lignociane 2%) if the weight of the child allowed supplementation, doseage not to exceed 5mg/kg body weight. Mode of administration, buccal or inferior alveolar block, and type of local anaesthetic used at first visit, test or control, determined by random allocation.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000873022